News

Independent Plexaris and Cevaris testing shows positive and unique results

12 February 2020 Melbourne, Australia: BioMAP testing of Exopharm’s exosome platform has validated safety and mechanism of action (MOA) and found that they have different and distinct activities compared to 4,500 other drugs. This confirms this therapeutic approach…

ARDC funding outcomes: Monash receives current funding for future tech

5 February 2020 Monash University has secured $4.3m from the Australian Research Data Commons (ARDC) to lead four major data and cloud infrastructure science projects, which significantly advance the artificial intelligence (AI), data science and research technology capabilities…

Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia

7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…

Milestone for HIV diagnostic

7 February 2020 Burnet Institute warmly welcomes Nigeria’s approval of a Burnet-developed diagnostic for adoption in the National HIV Control Program. The Omega VISITECT® CD4 350 test is a simple, low-cost rapid HIV diagnostic that can identify whether…

BioMelbourne Network Actions on the R&D Tax Incentive

8 February 2020 As you are aware, the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019 (the Bill) was introduced to the House of Representatives on 5 December 2019.  It will return to the House on…

New REDI grant funding validates ANDHealth model for digital health commercialisation

5 February 2020 ANDHealth will renew its commitment to turning innovative digital health ideas into commercial reality, after being named a beneficiary of a major new grant through its founding partner MTPConnect. The Federal Government’s Researcher Exchange and…

$5.5 million for international research collaborations in human health

6 February 2020 The Australian Government is investing $5.5 million in 10 ground-breaking medical research projects aimed at improving outcomes in mental health, dementia, aged care, cerebral palsy, diabetes and many more life-changing conditions. The Hon Greg Hunt…

Sienna makes Board Appointment

6 February 2020 ASX RELEASE Melbourne, Australia:  Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Tony Di Pietro as a Director of its Board. Tony has held the role of CFO and…

Sienna Increases European Presence Expanding into Finland with hTERT test

6 February 2020 ASX RELEASE Melbourne, Australia:  Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Immuno Diagnostic Oy as an exclusive distributor in Finland. The distribution agreement provides Immuno Diagnostic with the right…

Trajan’s hemaPEN® included on TGA’s ARTG as first blood microsampling device for use in Australia

7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…

Gut reaction: how immunity ramps up against incoming threats

30 January 2020 A new study has revealed how the gut’s protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits. Professor Gabrielle Belz (left)…

On-shore commercial manufacture and wider subsidy for CAR T-Cell therapy

28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…

Home

News & opinion

Member Directory

Events